SBRA Sabra Health Care REIT, Inc.

Nasdaq sabrahealth.com


$ 17.81 $ 0.20 (1.14 %)    

Thursday, 16-Oct-2025 15:59:58 EDT
QQQ $ 598.23 $ -2.23 (-0.37 %)
DIA $ 458.84 $ -3.15 (-0.68 %)
SPY $ 658.90 $ -4.53 (-0.68 %)
TLT $ 91.49 $ 0.68 (0.75 %)
GLD $ 401.79 $ 9.06 (2.34 %)
$ 17.8
$ 17.57
$ 17.50 x 30
$ 18.00 x 6
$ 17.52 - $ 17.84
$ 15.07 - $ 19.97
4,277,904
na
4.27B
$ 0.62
$ 23.41
TBD
na
na ($ 0.07)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2025 06-30-2025 10-Q
2 05-05-2025 03-31-2025 10-Q
3 02-19-2025 12-31-2024 10-K
4 10-31-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 02-21-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 08-03-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 02-22-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-05-2021 03-31-2021 10-Q
19 02-22-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-24-2020 12-31-2019 10-K
24 10-30-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 02-25-2019 12-31-2018 10-K
28 11-05-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 02-21-2018 12-31-2017 10-K
32 11-01-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 05-08-2017 03-31-2017 10-Q
35 02-22-2017 12-31-2016 10-K
36 11-02-2016 09-30-2016 10-Q
37 08-01-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 02-22-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-initiates-coverage-on-sabra-health-care-reit-with-neutral-rating-announces-price-target-of-20

Cantor Fitzgerald analyst Richard Anderson initiates coverage on Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral rating ...

 truist-securities-maintains-hold-on-sabra-health-care-reit-raises-price-target-to-20

Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Hold and raises the price targ...

 wells-fargo-maintains-overweight-on-sabra-health-care-reit-raises-price-target-to-21

Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overweight and raises the price t...

 bmo-capital-maintains-market-perform-on-sabra-health-care-reit-raises-price-target-to-22

BMO Capital analyst John Kim maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Market Perform and raises the price targe...

 jmp-securities-maintains-market-outperform-on-sabra-health-care-reit-raises-price-target-to-22

JMP Securities analyst Aaron Hecht maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Market Outperform and raises the pr...

 sabra-health-care-reit-announces-mixed-shelf-offering-size-not-disclosed

-SEC Filing

 sabra-health-care-reit-raises-fy2025-ffo-guidance-from-143-146-to-145-147-vs-146-est

Sabra Health Care REIT (NASDAQ:SBRA) raises FY2025 FFO guidance from $1.43-$1.46 to $1.45-$1.47 vs $1.46 analyst estimate..

 sabra-health-care-reit-q2-ffo-037-beats-036-estimate-sales-18915m-beat-18062m-estimate

Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate o...

 scotiabank-maintains-sector-perform-on-sabra-health-care-reit-raises-price-target-to-20

Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector Perform and raises the price...

 scotiabank-maintains-sector-perform-on-sabra-health-care-reit-raises-price-target-to-19

Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector Perform and raises the price...

 sabra-health-care-reit-affirms-fy2025-ffo-guidance-of-143-146-vs-146-est

Sabra Health Care REIT (NASDAQ:SBRA) affirms FY2025 FFO guidance from $1.43-$1.46 to $1.43-$1.46 vs $1.46 analyst estimate..

 sabra-health-care-reit-q1-ffo-035-misses-036-estimate-sales-18354m-beat-17838m-estimate

Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.35 per share which missed the analyst consensus estimate...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION